drugset / Trial / NCT03691831
A Study of A-101 Topical Solution for the Treatment of Common Warts
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Phase 3 Study of A-101 Topical Solution in Subjects with Common Warts
Timeline
- Start
- 2018-09-13
- Primary completion
- 2019-04-21
- Completion
- 2019-07-09
Outcome
Met primary endpoint
registry analysis (superiority test); Active vs Vehicle; p = 0.0001; Odds Ratio (OR) 4.80 (95% CI 2.14 to 10.76) NCT03691831 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrogen Peroxide | Small molecule | 45 % | Topical |